CLINICAL_TRIALS
trial_result
· 2019-01-29
Clinical Trial Update: Role of High Mobility Group Box 1 as a Prognostic Biomarker in Patients Undergoing Valvular Heart Surgery
Summary
Completed clinical trial evaluating high mobility group box 1 (HMGB1) as a prognostic biomarker in patients undergoing valvular heart surgery.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Yonsei University | Conditions: Valvular Heart Disease | Status: COMPLETED